Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares (688796)
SSE
Closed
Sep 18, 2026
Day's Range
128.2052 wk Range
48.06Overview - 688796 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
Key Statistics
Valuation
Enterprise Value
55.95B
P/E (Trailing)
‪145.83‬
Price / Sales (TTM)
‪31.98‬
Price / Book
‪22.60‬
EV / EBITDA
‪106.58‬
Profitability
Profit Margin
‪21.55%‬
Operating Margin
‪35.41%‬
Return on Assets
‪8.64%‬
Return on Equity
‪22.04%‬
Ownership
Shares Outstanding
336.11M
Float
155.45M
Held by Insiders
‪24.19%‬
Held by Institutions
‪39.45%‬
Price stats
Beta
‪0.14‬
50-Day Avg
‪123.87‬
200-Day Avg
‪93.12‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - 688796 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
Peers - 688796 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
- 688796SSEBiocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares53.41BMarket Cap+45.35%52-week change145.83P/E (Trailing)‪21.55%‬Profit Margin
- 688235SSEBeigene Ltd.363.67BMarket Cap-29.40%52-week change85.57P/E (Trailing)‪10.69%‬Profit Margin
- 688331SSERemeGen Co., Ltd.64.73BMarket Cap+8.05%52-week change10.99P/E (Trailing)‪72.71%‬Profit Margin
- 688428SSEInnoCare Pharma Ltd.46.51BMarket Cap-4.22%52-week change54.78P/E (Trailing)‪33.04%‬Profit Margin
- 688578SSEShanghai Allist Pharmaceuticals Co., Ltd.44.77BMarket Cap-12.78%52-week change16.75P/E (Trailing)‪43.67%‬Profit Margin
- 688336SSESunshine Guojian Pharmaceutical Co., Ltd.34.11BMarket Cap+0.89%52-week change11.10P/E (Trailing)‪69.64%‬Profit Margin
- 603392SSEBeijing Wantai Biological Pharmacy Enterprise Co., Ltd.33.22BMarket Cap-124.77%52-week change826.25P/E (Trailing)‪-18.90%‬Profit Margin
Profile Summary - 688796 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
About
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares represent an interest in a China-based biopharmaceutical company specializing in antibody-based drug discovery and preclinical research services. The company focuses on developing therapies targeting oncology, autoimmune, inflammatory, metabolic and other…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
